Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
David P. HochmanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 06/01 | 06/02 | 5,000 sh | $3.83 | $19,150 | +0.5% |
Darren ShermanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market sale10b5-1 plan | 06/01 | 06/02 | 15,000 sh | $3.87 | $58,050 | −1.3% |
Jason AryehDirector | Orchestra BioMed HoldingsOBIO | Open-market buy | 05/18 | 05/20 | 665 sh | $3.75 | $2,493.75 | +0.6% |
David P. HochmanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 05/15 | 05/19 | 5,000 sh | $3.77 | $18,850 | +0.5% |
Jason AryehDirector | Orchestra BioMed HoldingsOBIO | Open-market buy | 05/15 | 05/19 | 8,971 sh | $3.90 | $34,986.9 | +8.3% |
Eric S. FainDirector | Orchestra BioMed HoldingsOBIO | Open-market buy | 05/14 | 05/18 | 20,000 sh | $4.13 | $82,600 | +27.9% |
RTW Investments10% Owner | Orchestra BioMed HoldingsOBIO | Open-market sale | 04/27 | 04/29 | 32 sh | $4.13 | $132.16 | −0.0% |
Roderick Wong10% Owner | Orchestra BioMed HoldingsOBIO | Open-market sale | 04/27 | 04/29 | 32 sh | $4.13 | $132.16 | −0.0% |
David P. HochmanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 03/13 | 03/16 | 10,000 sh | $4.29 | $42,900 | +0.9% |
David P. HochmanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/11/14 | 25/11/17 | 5,000 sh | $4.07 | $20,350 | +0.8% |
Jason AryehDirector | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/09/19 | 25/09/19 | 1,000 sh | $2.45 | $2,450 | +0.9% |
Eric S. FainDirector | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/25 | 25/08/25 | 5,760 sh | $2.61 | $15,033.6 | +8.7% |
Darren ShermanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/25 | 25/08/25 | 3,000 sh | $2.62 | $7,860 | +0.3% |
Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/25 | 25/08/25 | 2,000 sh | $2.55 | $5,100 | +0.4% | |
David P. HochmanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/21 | 25/08/25 | 6,000 sh | $2.49 | $14,940 | +0.9% |
Joseph Edelman10% Owner | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/01 | 25/08/05 | 700,000 sh | $2.75 | $1,925,000 | +15.2% |
Perceptive Advisors10% Owner | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/01 | 25/08/05 | 700,000 sh | $2.75 | $1,925,000 | +15.2% |
Perceptive Life Sciences Master Fund10% Owner | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/01 | 25/08/05 | 700,000 sh | $2.75 | $1,925,000 | +15.2% |
David P. HochmanSEE REMARKS | Orchestra BioMed HoldingsOBIO | Open-market buy | 25/08/04 | 25/08/04 | 20,000 sh | $2.75 | $55,000 | +6.1% |
Eric S. FainDirector | Orchestra BioMed HoldingsOBIO | Open-market sale | 25/06/26 | 25/06/27 | 2,683 sh | $3.05 | $8,183.15 | −5.0% |